Exact Mass: 409.0923382

Exact Mass Matches: 409.0923382

Found 45 metabolites which its exact mass value is equals to given mass value 409.0923382, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

1-(5-Phosphoribosyl)-4-(N-succinocarboxamide)-5-aminoimidazole

[(2R,3S,4R,5R)-5-[5-amino-4-[(4-amino-4-oxo-butanoyl)amino]imidazol-1-yl]-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl dihydrogen phosphate

C12H20N5O9P (409.0998600000001)


   

DU-6859

SITAFLOXACINISOMER?(RSR)

C19H18ClF2N3O3 (409.1004692)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

   

Urea,3,4-tri-O-acetyl-D-ribopyranosyl)-

4,5-Bis(acetyloxy)-2-[N-(2-chloroethyl)-N-nitroso-(C-hydroxycarbonimidoyl)amino]oxan-3-yl acetic acid

C14H20ClN3O9 (409.088802)


   

7-[(7S)-7-Amino-5-azaspiro[2.4]heptan-5-yl]-8-chloro-6-fluoro-1-[(2S)-2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic acid

7-{7-amino-5-azaspiro[2.4]heptan-5-yl}-8-chloro-6-fluoro-1-(2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

C19H18ClF2N3O3 (409.1004692)


   

Lifibrate

1-Methylpiperidin-4-yl 2,2-bis(4-chlorophenoxy)acetic acid

C20H21Cl2NO4 (409.08475660000005)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent

   

Telatinib

4-[({4-[(4-chlorophenyl)amino]furo[2,3-d]pyridazin-7-yl}oxy)methyl]-N-methylpyridine-2-carboxamide

C20H16ClN5O3 (409.0941616)


   

Verubecestat

N-[3-(3-amino-2,5-dimethyl-1,1-dioxo-5,6-dihydro-2H-1lambda6,2,4-thiadiazin-5-yl)-4-fluorophenyl]-5-fluoropyridine-2-carboxamide

C17H17F2N5O3S (409.1020116000001)


   
   

cladoniamide D

cladoniamide D

C21H16ClN3O4 (409.08292860000006)


An organic heteropentacyclic compound that is cladoniamide E in which the chlorine attached to the methoxy-bearing indole moiety is replaced by a hydrogen. It has been isolated from the culture broth of Streptomyces uncialis.

   
   

cladoniamide F

cladoniamide F

C21H16ClN3O4 (409.08292860000006)


An organic heteropentacyclic compound that is cladoniamide G in which the chlorine attached to the methoxy-bearing indole moiety is replaced by a hydrogen. It has been isolated from the culture broth of Streptomyces uncialis.

   
   

(R)-2-Benzyloxycarbonylamino-1,5-dimethanesulfonyloxypentane

(R)-2-Benzyloxycarbonylamino-1,5-dimethanesulfonyloxypentane

C15H23NO8S2 (409.0865038)


   

N-(3-chloro-4-fluorophenyl)-7-methoxy-6-phenylmethoxyquinazolin-4-amine

N-(3-chloro-4-fluorophenyl)-7-methoxy-6-phenylmethoxyquinazolin-4-amine

C22H17ClFN3O2 (409.0993264)


   
   
   

5-Chloro-N-[(2R)-2-hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-2-thiophenecarboxamide

5-Chloro-N-[(2R)-2-hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-2-thiophenecarboxamide

C18H20ClN3O4S (409.0862990000001)


   

10-hydroxy-9-nitrocamptothecin

10-hydroxy-9-nitrocamptothecin

C20H15N3O7 (409.090996)


   

Sitafloxacin

7-[(7r)-7-Amino-5-azaspiro[2.4]hept-5-yl]-8-chloro-6-fluoro-1-[(1s,2r)-2-fluorocyclopropyl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

C19H18ClF2N3O3 (409.1004692)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

   

Prasugrel hydrochloride

Prasugrel hydrochloride

C20H21ClFNO3S (409.09146380000004)


C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent > C190801 - P2Y12 Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Prasugrel hydrochloride (PCR 4099 hydrochloride), a thienopyridine and proagent, inhibits platelet function. Prasugrel hydrochloride is an orally active and potent P2Y12 receptor antagonist, and inhibits ADP-induced platelet aggregation[1].

   
   

Telatinib

Telatinib

C20H16ClN5O3 (409.0941616)


C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor

   

MK-8931

Verubecestat

C17H17F2N5O3S (409.1020116000001)


C26170 - Protective Agent > C1509 - Neuroprotective Agent C471 - Enzyme Inhibitor

   

[4,5-Diacetyloxy-6-[[2-chloroethyl(nitroso)carbamoyl]amino]oxan-3-yl] acetate

[4,5-Diacetyloxy-6-[[2-chloroethyl(nitroso)carbamoyl]amino]oxan-3-yl] acetate

C14H20ClN3O9 (409.088802)


   

lifibrate

lifibrate

C20H21Cl2NO4 (409.08475660000005)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent

   

Aklaviketone(1-)

Aklaviketone(1-)

C22H17O8- (409.0923382)


A phenolate anion obtained by deprotonation of 5-hydroxy group of aklaviketone. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   

Methyl aklanonate(1-)

Methyl aklanonate(1-)

C22H17O8- (409.0923382)


   

N-(1,3-benzodioxol-5-yl)-2-[(8-methoxy-5H-[1,2,4]triazino[5,6-b]indol-3-yl)thio]acetamide

N-(1,3-benzodioxol-5-yl)-2-[(8-methoxy-5H-[1,2,4]triazino[5,6-b]indol-3-yl)thio]acetamide

C19H15N5O4S (409.08447100000006)


   

1-(3-chloro-4-methoxyphenyl)sulfonyl-N-(3-pyridinyl)-3-piperidinecarboxamide

1-(3-chloro-4-methoxyphenyl)sulfonyl-N-(3-pyridinyl)-3-piperidinecarboxamide

C18H20ClN3O4S (409.0862990000001)


   

(2-Methyl-[1,3]dioxolan-2-yl)-acetic acid [1-(3,4-dichloro-phenyl)-2,5-dimethyl-1H-pyrrol-3-ylmethylene]-hydrazide

(2-Methyl-[1,3]dioxolan-2-yl)-acetic acid [1-(3,4-dichloro-phenyl)-2,5-dimethyl-1H-pyrrol-3-ylmethylene]-hydrazide

C19H21Cl2N3O3 (409.09598960000005)


   
   
   
   
   

orlandin(1-)

orlandin(1-)

C22H17O8 (409.0923382)


A phenolate anion resulting from the deprotonation of the 7-hydroxy group orlandin. It is the major microspecies at pH 7.3.

   

desertorin A(1-)

desertorin A(1-)

C22H17O8 (409.0923382)


A phenolate anion that is the conjugate base of desertorin A, obtained by deprotonation of 7-hydroxy group of desertorin A. It is the major microspecies at pH 7.3.

   

AT7867 (dihydrochloride)

AT7867 (dihydrochloride)

C20H22Cl3N3 (409.08792220000004)


AT7867 dihydrochloride is a potent ATP-competitive inhibitor of Akt1/Akt2/Akt3 and p70S6K/PKA with IC50s of 32 nM/17 nM/47 nM and 85 nM/20 nM, respectively.

   

(11r)-7-chloro-11-hydroxy-20-methoxy-n-methyl-12-oxo-3,13-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]icosa-1(20),2(10),4,6,8,14,16,18-octaene-11-carboximidic acid

(11r)-7-chloro-11-hydroxy-20-methoxy-n-methyl-12-oxo-3,13-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]icosa-1(20),2(10),4,6,8,14,16,18-octaene-11-carboximidic acid

C21H16ClN3O4 (409.08292860000006)


   

7-chloro-11-hydroxy-20-methoxy-n-methyl-12-oxo-3,13-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]icosa-1(20),2(10),4,6,8,14,16,18-octaene-11-carboximidic acid

7-chloro-11-hydroxy-20-methoxy-n-methyl-12-oxo-3,13-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]icosa-1(20),2(10),4,6,8,14,16,18-octaene-11-carboximidic acid

C21H16ClN3O4 (409.08292860000006)


   

(2r)-3-{[(1-hydroxy-3,6-dimethoxy-5,8-dioxonaphthalen-2-yl)methyl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid

(2r)-3-{[(1-hydroxy-3,6-dimethoxy-5,8-dioxonaphthalen-2-yl)methyl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid

C18H19NO8S (409.0831334)


   

(2r)-3-({[1-hydroxy-7-(hydroxymethyl)-3-methoxy-5,8-dioxonaphthalen-2-yl]methyl}sulfanyl)-2-[(1-hydroxyethylidene)amino]propanoic acid

(2r)-3-({[1-hydroxy-7-(hydroxymethyl)-3-methoxy-5,8-dioxonaphthalen-2-yl]methyl}sulfanyl)-2-[(1-hydroxyethylidene)amino]propanoic acid

C18H19NO8S (409.0831334)


   

7-chloro-12-hydroxy-20-methoxy-n-methyl-11-oxo-3,13-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]icosa-1(20),2(10),4,6,8,14,16,18-octaene-12-carboximidic acid

7-chloro-12-hydroxy-20-methoxy-n-methyl-11-oxo-3,13-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]icosa-1(20),2(10),4,6,8,14,16,18-octaene-12-carboximidic acid

C21H16ClN3O4 (409.08292860000006)


   

(2r)-3-{[(1,3-dihydroxy-6-methoxy-7-methyl-5,8-dioxonaphthalen-2-yl)methyl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid

(2r)-3-{[(1,3-dihydroxy-6-methoxy-7-methyl-5,8-dioxonaphthalen-2-yl)methyl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid

C18H19NO8S (409.0831334)


   

(12s)-7-chloro-12-hydroxy-20-methoxy-n-methyl-11-oxo-3,13-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]icosa-1(20),2(10),4,6,8,14,16,18-octaene-12-carboximidic acid

(12s)-7-chloro-12-hydroxy-20-methoxy-n-methyl-11-oxo-3,13-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]icosa-1(20),2(10),4,6,8,14,16,18-octaene-12-carboximidic acid

C21H16ClN3O4 (409.08292860000006)